Bakuchiol vs retinol comes down to one honest question: does the gentler option actually do the same job? One head-to-head trial says close to it, with less irritation, and it is a small trial. This blog will walk you through what the evidence shows, where the gaps sit, and which skin each ingredient suits.
What is bakuchiol, and is it really a plant retinol?
Bakuchiol is a meroterpene phenol extracted from the seeds and leaves of Psoralea corylifolia, the plant known as babchi. It appears in Ayurvedic and Traditional Chinese medical traditions, and entered mainstream skincare only in the last decade.
The “plant retinol” label is marketing shorthand, and it is chemically wrong. Retinol is a form of vitamin A that skin cells convert to retinoic acid, which then binds retinoic acid receptors and switches on the genes behind collagen synthesis and cell turnover. Bakuchiol shares no structural relationship with vitamin A and does not follow that conversion path. What it does share is the destination: gene expression profiling has shown bakuchiol upregulates a similar set of skin genes, which is why the effects look alike on the face while the biology underneath differs.
That distinction is not academic. It explains why the two behave differently on tolerance, on sun exposure, and on the pregnancy question further down.
How do bakuchiol and retinol compare?
The table sets both against the same attributes. Every efficacy and tolerability row comes from the single trial that tested them head to head, described in the section below.
| Bakuchiol | Retinol | |
| What it is | Meroterpene phenol from Psoralea corylifolia seeds | Vitamin A derivative |
| How it works | Retinoid-like gene expression without the retinoic acid conversion pathway | Converted in skin to retinoic acid, which binds retinoic acid receptors |
| Head-to-head efficacy | Reduced wrinkle surface area and pigmentation over 12 weeks | Reduced wrinkle surface area and pigmentation over 12 weeks, no statistical difference |
| Dose in that trial | 0.5%, twice daily | 0.5%, once daily |
| Tolerability | Less scaling and stinging reported | More scaling and stinging reported |
| Evidence base | One 44-person head-to-head trial plus supporting laboratory and clinical work | Decades of clinical trials across multiple indications |
| Light stability | Photochemically stable, usable in the morning | Degrades in light, applied at night |
| Adjustment period | Usually none | Retinisation period of dryness and flaking is common |
| Pregnancy | No human safety data; no known mechanism of harm; not established as safe | Avoided, on the basis of vitamin A derivative concerns |
The row people skip is the dose row. Bakuchiol matched retinol in that trial while being applied twice as often, which is a fair comparison of two real-world routines but not a milligram-for-milligram equivalence. Anyone reading “just as good” should read “just as good, applied twice a day”.
What does the research actually show?
One randomised, double-blind, 12-week trial published in the British Journal of Dermatology put the two ingredients directly against each other. Forty-four participants applied either 0.5% bakuchiol cream twice daily or 0.5% retinol cream once daily, with high-resolution facial photography at weeks 0, 4, 8 and 12 and a blinded dermatologist grading pigmentation and redness at each visit.
The finding was that both significantly decreased wrinkle surface area and hyperpigmentation, with no statistical difference between the compounds, while retinol users reported more facial skin scaling and stinging. The authors concluded bakuchiol is comparable with retinol for photoageing and better tolerated.
Two caveats belong alongside that result, and leaving them out is how a reasonable finding turns into an overclaim. Forty-four participants over twelve weeks is a small, short trial, and a single study is a starting point rather than a settled answer. Retinol carries decades of accumulated data across far larger populations. The honest reading is that bakuchiol has earned serious consideration, not that the two are interchangeable.
The mechanism work sits underneath the clinical result. Gene expression profiling by Chaudhuri and Bojanowski found bakuchiol regulates a retinol-like set of genes, including collagen types I and IV, without acting through the retinoic acid receptor route. That is the reason a non-retinoid produces retinoid-like results.
Why does bakuchiol suit sensitive and reactive skin?
Bakuchiol suits reactive skin because it skips the retinisation period. Retinol commonly produces several weeks of dryness, flaking, and stinging as skin adjusts, and that adjustment is exactly what people with an already-compromised barrier cannot absorb. The head-to-head trial reflected this: scaling and stinging clustered in the retinol group.
For sensitive skin and rosacea the calculation shifts further. Rosacea skin has a compromised barrier and an active inflammatory process, so an ingredient that provokes irritation works against the treatment goal even when it delivers benefit on paper. Retinoids are usually avoided during an active rosacea flare for that reason. Bakuchiol is a reasonable option to discuss with a dermatologist in that situation, though “gentler” is not the same as “guaranteed tolerated”, and patch testing still applies.
Where this breaks down is treating gentleness as a reason to skip the introduction protocol. Any new active goes on alone, patch tested, with a fortnight before the next addition, whatever its reputation.
When and how should you use bakuchiol?
Bakuchiol is photostable, which is the practical difference that shapes the routine. Retinol degrades in light and belongs at night. Bakuchiol does not, so it can go in either the morning or evening routine, applied after cleansing and before moisturiser.
It combines comfortably with hyaluronic acid, niacinamide, peptides, and vitamin C, none of which compete with it or destabilise it. Start once daily rather than twice, and build up if your skin is comfortable after two weeks. Judge results on the trial’s timescale rather than a fortnight’s: measurable change in that study appeared across 12 weeks, with assessments at 4 and 8 weeks along the way.
Formulation matters more than the percentage on the front of the bottle. Bakuchiol needs to be stabilised properly and delivered in a base that suits the skin using it, which is the same reason two products at the same concentration can behave differently. Choosing actives by evidence and by skin type rather than by ingredient trend is the whole argument behind the Skincodes method, and bakuchiol is a good test case for it.
Purified bakuchiol is not babchi oil
One distinction protects people from the worst version of this ingredient. Purified topical bakuchiol is a standardised, refined extract. Unrefined babchi oil and vaguely labelled Psoralea corylifolia extract are different materials, and they can carry phototoxic and allergenic compounds that the purified form does not. Homemade infusions of babchi seed sit further down the same slope. If a label lists only “Psoralea corylifolia extract” or “babchi oil” without a stated bakuchiol content, that is not the ingredient the research was done on.
Is bakuchiol safe during pregnancy?
Bakuchiol has not been established as safe in pregnancy, and the honest answer is that nobody knows. No human pregnancy safety trials exist for topical bakuchiol, and it carries no assigned pregnancy safety rating. What the reassurance actually rests on is the absence of a known mechanism of harm: bakuchiol is not a vitamin A derivative, does not convert to retinoic acid, and does not act through the receptor pathway that underlies retinoid teratogenicity concerns.
That is a meaningful difference from retinol, and it is why bakuchiol comes up in this conversation at all. It is not the same as demonstrated safety, and any page telling you it is has skipped a step. Lower known risk and confirmed safe are two different statements.
The purified-versus-crude distinction matters more here than anywhere else, since oral Psoralea corylifolia preparations have a different pharmacological profile from a refined topical extract and should not be reasoned about together.
The practical position: if you are pregnant or breastfeeding and want to use bakuchiol, that decision belongs with your doctor or obstetrician alongside the rest of your routine, not with an ingredient article. Bring the actual product and its full ingredient list to the conversation.
Who is bakuchiol actually for?
Bakuchiol earns its place for people who have tried retinol and could not stay on it. That is a larger group than the marketing suggests, and abandoning an effective ingredient because the adjustment period was intolerable is a common outcome rather than a rare one.
It also suits reactive and redness-prone skin, anyone wanting a morning-compatible active, and people who want to start slowly before considering a retinoid later. Bakuchiol and retinol are not mutually exclusive: some routines use bakuchiol in the morning and a retinoid at night, once the skin tolerates both.
Where retinol still wins is depth of evidence and prescription strength. For established photoageing, significant textural change, or conditions where a retinoid is part of medical treatment, a prescription-grade option assessed by a dermatologist does things a cosmetic ingredient does not. Choosing between them is a skin assessment, not a shopping decision, which is why the clinic skincare range is built around matching actives to an actual diagnosis rather than to whatever is trending.
Conclusion
Bakuchiol is a credible ingredient with one good trial behind it, not a plant version of retinol and not a marketing invention. It matched 0.5% retinol on wrinkles and pigmentation over 12 weeks while causing less scaling and stinging, applied twice as often, in a study of 44 people. For skin that cannot tolerate retinol, that is a genuinely useful finding. For pregnancy, the correct answer is still that the safety data does not exist. If you are choosing between actives and not sure which your skin needs, book a consultation with Dr Ang Sue-May at Skincodes and have the routine built around a diagnosis instead of a trend.
Frequently asked questions
Is bakuchiol as effective as retinol?
In the one randomised head-to-head trial, 0.5% bakuchiol twice daily matched 0.5% retinol once daily on wrinkle surface area and pigmentation over 12 weeks, with no statistical difference. That trial included 44 people. Retinol still carries a far larger evidence base across decades of research.
Can you use bakuchiol and retinol together?
Yes, though there is no need to use both at once. Some routines apply bakuchiol in the morning, since it is photostable, and a retinoid at night. Introduce one at a time and give each a fortnight before adding the other, so any irritation can be attributed to the right ingredient.
How long does bakuchiol take to work?
Measurable change appeared over 12 weeks in the head-to-head trial, with assessments at 4 and 8 weeks along the way. Expect gradual improvement rather than a rapid shift, and judge the result at three months rather than three weeks. Consistency matters more than concentration at this stage.
Does bakuchiol cause purging like retinol?
Bakuchiol does not typically produce the retinisation period of dryness, flaking and stinging that retinol causes, and trial participants reported less scaling and stinging than the retinol group. That is a tolerability difference, not a guarantee. Reactive skin can still react, so patch test before applying it across the face.
Can bakuchiol be used with vitamin C and niacinamide?
Yes. Bakuchiol combines comfortably with vitamin C, niacinamide, hyaluronic acid and peptides, none of which destabilise it or compete with it. The practical limit is how many leave-on products your skin tolerates at once, which matters more in humid climates where layering traps heat and sweat.
Is bakuchiol suitable for rosacea-prone skin?
It may be, and it should be discussed with a dermatologist rather than assumed. Retinoids are usually avoided during active rosacea flares because they irritate a compromised barrier. Bakuchiol is better tolerated in general, but rosacea skin reacts unpredictably, so patch testing and a settled baseline come first.
Is bakuchiol safe to use in pregnancy?
No human pregnancy safety trials exist for topical bakuchiol, so it cannot be called confirmed safe. It is not a vitamin A derivative and carries no known mechanism for the concerns attached to retinoids, which is why it is considered lower risk. Confirm with your doctor before using it while pregnant or breastfeeding.